艾滋病毒儿科配方中的微封装技术:进展和未来前景
1Department of Pharmaceutical Sciences, University of the Western Cape, Robert Sobukwe Drive, Bellville, Cape Town, South Africa.
Advances in pharmacological and pharmaceutical sciences
|October 18, 2024
概括
儿童艾滋病毒治疗面临挑战,因为缺乏授权的抗逆转录病毒药物 (ARVDs). 先进的微封装技术为口味掩饰提供了解决方案,并改善了儿童的药物输送.
科学领域:
- 制药科学 制药科学
- 儿科药理学 儿科药理学
- 药物输送系统 药物输送系统
背景情况:
- 儿科艾滋病毒治疗反映了成人治疗方案,缺乏专门的儿科抗逆转录病毒药物 (ARVD) 配方.
- 在儿童中未经许可的ARVD导致坚持问题,治疗失败,以及由于药片大小,可口性和溶解性差等因素而引起的不良反应.
研究的目的:
- 审查先进的微封装技术,以开发改进的儿科艾滋病毒配方.
- 解决包括口味掩饰,溶解性,生物可用性和可口性在儿科药物输送中的挑战.
主要方法:
- 关于微封装策略及其在药物输送中的应用的文献综述.
- 对纳米粒子封装进行分析,以提高可溶性,生物可用性和口味掩饰.
- 对儿童配方微化粉末生产的检查.
主要成果:
- 微封装在克服常见的儿科配方限制方面显示出显著的潜力.
- 诸如口味掩饰和提高溶解度等技术对于儿科ARVD至关重要.
- 有限的研究存在于专门用于小儿艾滋病毒配方的微封装的应用.
结论:
- 微封装为创建有效和儿童友好的儿科艾滋病毒治疗提供了一个有希望的途径.
- 对微封装策略的进一步研究对于推进儿科艾滋病毒药物治疗至关重要.
- 开发专门的儿科配方可以显著改善治疗结果和治疗坚持.
相关概念视频
Microorganisms in Medicine and Therapeutics
2
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
2
Retrovirus Life Cycles
45.7K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.7K


